Faculty Bios

Chair:

Peg Esper, DNP, ANP-BC, AOCN®
Adjunct Clinical Instructor
Nurse Practitioner    University of Michigan School of Nursing
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan

Peg Esper works as a Nurse Practitioner in a collaborative practice at the University of Michigan Comprehensive Cancer Center in Ann Arbor. She has certifications as a nurse practitioner and an advanced oncology nurse. Dr. Esper is a frequent speaker at local, national, and international forums, addressing topics such as targeted therapy, immunotherapy, and palliative care. She edited two palliative care textbooks and has written numerous manuscripts and book chapters about cancer-related topics. Dr. Esper received a DNP from the University of Michigan in Ann Arbor; an MSN from Oakland University, Rochester, Michigan; and an MSA in health care administration from Central Michigan University, Mount Pleasant, Michigan.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant:

Peg Esper, DNP, MSN, MSA, ANP-BC, AOCN®, has no real or apparent conflicts of interest to report.

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following AXIS planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Linda Gracie-King, MS, and Deborah Middleton, MS, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.


Faculty Speakers:

Marianne Davies, DNP, ACNP, AOCNP®
Oncology Nurse Practitioner – Thoracic
Smilow Cancer Center at Yale New Haven
Assistant Professor
Yale School of Nursing 
New Haven, Connecticut

Marianne Davies is an Assistant Professor of Nursing at Yale School of Nursing in New Haven, Connecticut. Her academic focus is on professional development, advanced assessment, and health promotion for the Masters of Nursing nurse practitioner program. She has extensive experience in clinical oncology and clinical trials for patients with thoracic malignancies and has been instrumental in the treatment of patients receiving novel therapies such as immunotherapy. Dr. Davies presented and published monographs, peer-reviewed articles, and book chapters about the treatment and symptom management of lung cancer. She has also presented and published on role development and transitions in practice for nurse practitioners. She was a fellow in the Leadership Development Institute of the Oncology Nursing Society. Dr. Davies received a DNP with concentrations in education and leadership from MGH Institute of Health Professions in Boston, Massachusetts, and an MSN from Yale School of Nursing in Orange, Connecticut. 


Jason L. Luke, MD FACP
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, Illinois
 

Jason J. Luke is an Assistant Professor of Medicine at the University of Chicago, where he specializes in the management of melanoma and early phase drug development. Dr. Luke received an MD degree from Rosalind Franklin University of Medicine and Science in North Chicago. He then pursued an internship and residency at the Boston University Medical Center followed by medical and medical oncology fellowships at Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center in New York City. Following the fellowship, Dr. Luke was a tenure-track, type 1 Instructor in medicine at Harvard Medical School as well as Staff Physician at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital. He was then recruited to the University of Chicago to develop a comprehensive melanoma research program and bolster investigation into early drug development of immunotherapeutic agents.

Dr. Luke is actively involved in the Society for Melanoma Research, the Society for Immunotherapy of Cancer, and the American Society for Clinical Oncology (ASCO). In 2014, he served as the chair of the education committee and as a member of the scientific committee for the melanoma track of the ASCO annual meeting. Dr. Luke received a Young Investigator Award from the Conquer Cancer Foundation of the ASCO, an ASCO Merit Award, the Denise and Michael Kellen Young Investigator Award from the Melanoma Research Alliance, and a Paul Calabresi Career Development in Clinical Oncology Award. Dr. Luke’s research has been supported by ASCO, the National Comprehensive Cancer Network®, and the National Cancer Institute.